Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days
ABSTRACT Cryptococcal meningoencephalitis is an urgent global health problem. Induction regimens using 14 days of amphotericin B deoxycholate (dAmB) are considered the standard of care but may not be suitable for resource-poor settings. We investigated the efficacy of conventional and abbreviated re...
Guardado en:
Autores principales: | Joanne Livermore, Susan J. Howard, Andrew D. Sharp, Joanne Goodwin, Lea Gregson, Timothy Felton, Julie A. Schwartz, Catherine Walker, Bill Moser, Werner Müller, Thomas S. Harrison, John R. Perfect, William W. Hope |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a0ec99c0b4747cc8c65fa78b99ab9e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
por: R. Lu, et al.
Publicado: (2019) -
Quality of life of HIV-negative, previously healthy individuals following cryptococcal meningoencephalitis
por: Owen Dean, et al.
Publicado: (2021) -
Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice
por: Chen JH, et al.
Publicado: (2011) -
CCR2 Signaling Promotes Brain Infiltration of Inflammatory Monocytes and Contributes to Neuropathology during Cryptococcal Meningoencephalitis
por: Jintao Xu, et al.
Publicado: (2021) -
Choroid Plexitis and Ependymitis by Magnetic Resonance Imaging are Biomarkers of Neuronal Damage and Inflammation in HIV-negative Cryptococcal Meningoencephalitis
por: Dima A. Hammoud, et al.
Publicado: (2017)